Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 32.30
-1.80 (-5.28%)
Dec 8, 2025, 1:40 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.88 billion as of December 5, 2025. Its market cap has decreased by -52.71% in one year.
Market Cap
1.88B
Enterprise Value
2.06B
Revenue
2.76B
Ranking
n/a
PE Ratio
13.03
Stock Price
32.30
Market Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.88B, an increase of 4,436.76%. That is a compound annual growth rate of 46.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.88B | -48.86% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | 6.50B | 700.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.36T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 710.38B |
| Alkem Laboratories | 676.62B |